Skip to main content
OpenTrials

Clinical trial condition

Aortic Valve Disease

Explore clinical trials studying Aortic Valve Disease. Study availability and eligibility vary by location and protocol.

1,015 public trials 264 recruiting studies
Refine in advanced search Browse all conditions

Aortic Valve Disease trial results

Completed

Dose-finding Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CK-3773274 in Adults With Hypertrophic Cardiomyopathy

NCT04219826

Conditions
Aortic Stenosis, Subvalvular, Aortic Valve Disease, Aortic Valve Stenosis, +6 more
Locations
  • Cedar-Sinai Medical Center Los Angeles, California, United States
  • UCSF Medical Center San Francisco, California, United States
  • Northwestern University Evanston, Illinois, United States
  • Tufts Medical Center Boston, Massachusetts, United States
View all 22 locations
View Trial Details
Completed

A Long-Term Safety Extension Study of Mavacamten in Adults Who Have Completed MAVERICK-HCM or EXPLORER-HCM

NCT03723655

Conditions
Aortic Stenosis, Subvalvular, Aortic Valve Disease, Aortic Valve Stenosis, +8 more
Locations
  • Local Institution - 0045 Scottsdale, Arizona, United States
  • Local Institution - 0058 Los Angeles, California, United States
  • Local Institution - 0066 San Francisco, California, United States
  • Local Institution - 0063 Stanford, California, United States
View all 68 locations
View Trial Details
Completed

Prospective Evaluation of Neurocognition in Patients Undergoing Transcatheter Aortic Valve Replacement

NCT05614986

Conditions
Aortic Stenosis, Aortic Valve Disease, Aortic Valve Stenosis, +9 more
Locations
  • Baylor Heart and Vascular Hospital Dallas, Texas, United States
  • Baylor Scott & White All Saints at Fort Worth Fort Worth, Texas, United States
  • Baylor Scott and White The Heart Hospital Baylor Plano Plano, Texas, United States
  • Baylor Scott & White Medical Center - Temple Temple, Texas, United States
View Trial Details
Completed

A Study of Mavacamten in Obstructive Hypertrophic Cardiomyopathy

NCT05414175

Conditions
Aortic Stenosis, Subvalvular, Aortic Valve Disease, Aortic Valve Stenosis, +6 more
Locations
  • Local Institution - 0020 Uwajima, Ehime, Japan
  • Local Institution - 0026 Himeji-Shi, Hyōgo, Japan
  • Local Institution - 0016 Kobe, Hyōgo, Japan
  • Local Institution - 0017 Tsukuba, Ibaraki, Japan
View all 20 locations
View Trial Details
Completed

An Open-Label Study of Aficamten for Chinese Patients With Symptomatic oHCM

NCT06116968

Conditions
Aortic Stenosis, Subvalvular, Aortic Valve Disease, Aortic Valve Stenosis, +6 more
Locations
  • Beijing Anzhen Hospital Beijing, China
  • Beijing Chao-yang Hospital, Capital Medical University Beijing, China
  • Fuwai Hospital, CAMS & PUMC Beijing, China
  • Peking University Third Hospital Beijing, China
View Trial Details
Completed

The PROTEMBO Trial

NCT05873816

Conditions
Aortic Valve Disease, Aortic Valve Stenosis, Cardiovascular Diseases, +4 more
Locations
  • Tucson Medical Center Health Tucson, Arizona, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • BayCare Health System / Morton Plant Hospital Clearwater, Florida, United States
  • University of Michigan Ann Arbor, Michigan, United States
View all 20 locations
View Trial Details
Completed

Alwide Plus China Post-market Clinical Investigation

NCT07304427

Conditions
Aortic Valve Disease, Aortic Valve Stenosis, Cardiovascular Diseases, +5 more
Locations
  • Affiliated Hospital of Guangdong Medical University Zhanjiang, Guangdong, China
  • Jiangxi Provincial People's Hospital Nanchang, Jiangxi, China
  • Yan'an Hospital of Kunming City Kunming, Yunnan, China
  • Guangdong Provincial People's Hospital Guangzhou, China
View Trial Details

Related conditions